BMI View: The combined value of Saudi Arabia's pharmaceutical and healthcare markets is the largest in
the Middle East and Africa region. The Kingdom's National Transformation Program, a key part of Vision
2030, reinstates the government's commitment to improving heal ..."
BMI View: Over the forthcoming years, growth in Saudi Arabia's pharmaceutical and healthcare markets
will remain elevated. The government's ongoing commitment to sector development will continue to attract
investments from multinational drugmakers and healthcare compa ..."
BMI View: High per capita spending on pharmaceuticals and a rising burden of chronic diseases will
support long-term pharmaceutical growth in Saudi Arabia. However, a prolonged period of subdued oil
prices may see Saudi Arabia cut back on high value drug spending - po ..."
BMI View: Saudi Arabia's sophisticated healthcare system, large market size and government commitment
to sector development will continue to attract investments from international pharmaceutical and
healthcare companies. The fierce competition among multinationals and ..."
BMI View: Over the forthcoming years, growth in Saudi Arabia's pharmaceutical market will remain
elevated. The government's commitment to the sector and health insurance expansion will be key drivers of
sector growth, with the risks from lower oil prices and the Gulf ..."
BMI View: Saudi Arabia will deliver on its intentions to increase spending for the healthcare sector in 2015,
despite lower oil prices. The government regards the sector as pivotal to political stability and we believe
that actual spending will yet again exceed the am ..."
BMI View: We expect heavy investment into Saudi Arabia's healthcare sector to continue, particularly as
the government sees the sector as key to the diversification of the economy. The medical tourism industry in
particular provides opportunities for both pharmaceutical and med ..."
BMI View: Saudi Arabia's economic, demographic, epidemiological and political factors will shape the
provision of healthcare across the nation. Healthcare spending will be greatly boosted by government
initiatives. The new health projects will increase access to healt ..."
BMI View: Increasing investment from both the public and private sectors in the Saudi Arabian healthcare
industry will improve standards of care and increase access to medicines, as well as make the country a
more attractive destination for medical tourisms. More stri ..."
BMI View: We hold a very positive outlook towards growth in the Saudi Arabian medicines market over the
next decade, with pharmaceutical demand underpinned by a number of factors. However, risks to our
outlook are to the downside, some of which include greater-than-ex ..."